References
- Skirrow MB. Campylobacter enteritis: a ‘new’ disease. BMJ 1977; 2: 9–11
- Friedman C R, Neimann J, Wegener H C, Tauxe RV. Epidemiology of Campylobacter jejuni infections in the United States and other industrialized nations. Campylobacter, 2nd edn, I Nachamkin, MJ Blaser. American Society for Microbiology, Washington, DC 2000; 121–38
- Van Damme P. Taxonomy of the family Campylobacteraceae. Campylobacter, 2nd edn, I Nachamkin, MJ Blaser. American Society for Microbiology, Washington, DC 2000; 3–26
- Lawson A J, Logan J M, O'Neill G L, Desai M, Stanley J. Large-scale survey of Campylobacter species in human gastroenteritis by PCR and PCR-enzyme-linked immuno-sorbent assay. J Clin Microbiol 1999; 37: 3860–4
- Engberg J, On S LW, Harrington C S, Gerner-Smidt P. Prevalence of Campylobacter, Arcobacter, Helicobacter, and Sutterella spp. in human fecal samples as estimated by a reevaluation of isolation methods for Campylobacters. J Clin Microbiol 2000; 38: 286–91
- Nachamkin I. Campylobacter and Arcobacter. Manual of clinical microbiology, 7th edn, PR Murray, EJ Baron, MA Pfaller, FC Tenover, RH Yolken. American Society for Microbiology, Washington, DC 1999; 716–26
- Rautelin H, Jusufovic J, Hanninen ML. Identification of hippurate-negative thermophilic campylobacters. Diagn Microbiol Infect Dis 1999; 35: 9–12
- Ketley JM. Virulence of Campylobacter species: a molecular genetic approach. J Med Microbiol 1995; 42: 312–27
- Black R E, Levine M M, Clements M L, Hughes T P, Blaser MJ. Experimental Campylobacter jejuni infection in humans. J Infect Dis 1988; 157: 472–9
- Wassenaar TM. Toxin production by Campylobacter spp. Clin Microbiol Rev 1997; 10: 466–76
- Parkhill J, Wren B W, Mungall K, Ketley J M, Churcher C, Basham D. The genome sequence of the food-borne pathogen Campylobacter jejuni reveals hypervariable sequences. Nature 2000; 403: 665–8
- Pitkanen T, Ponka A, Pettersson T, Kosunen TU. Campylobacter enteritis in 188 hospitalized patients. Arch Intern Med 1983; 143: 215–9
- Peterson MC. Rheumatic manifestations of Campylobacter jejuni and C. fetus infections in adults. Scand J Rheumatol 1994; 23: 167–70
- Allos MB. Association between Campylobacter infection and Guillain-Barre syndrome. J Infect Dis 1997; 176: S125–8, (Suppl 2)
- Yuki N. Molecular mimicry between gangliosides and lipopolysaccharides of Campylobacter jejuni isolated from patients with Guillain-Barrk syndrome and Miller Fisher syndrome. J Infect Dis 1997; 176: S150–3, (Suppl 2)
- Rautelin H I, Kosunen TU. Campylobacter etiology in human gastroenteritis demonstrated by antibodies to acid extract antigen. J Clin Microbiol 1987; 25: 1944–51
- Blaser M J, Duncan DJ. Human serum antibody response to Campylobacter jejuni infection as measured in an enzyme-linked immunosorbent assay. Infect Immun 1984; 44: 292–8
- Reina J, Ros M J, Serra A. Susceptibilities to 10 antimicrobial agents of 1220 Campylobacter strains isolated from 1987 to 1993 from feces of pediatric patients. Antimicrob Agents Chemother 1994; 38: 2917–20
- Endtz H P, Ruijs C J, Van Klingeren B, Jansen W H, Van der Reijden T, Mouton RP. Quinolone resistance in campylobacter isolated from man and poultry following the introduction of fluoroquinolones in veterinary medicine. J. Antimicrob Chemother 1991; 27: 199–208
- Smith K E, Besser J M, Hedberg C W, Craig W, Leano F T, Bender J B. Quinolone-resistant Campylobacter jejuni infections in Minnesota, 1992–1998. N Engl J Med 1999; 340: 1525–32
- Rautelin H, Renkonen O V, Kosunen TU. Emergence of fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli in subjects from Finland. Antimicrob Agents Chemother 1991; 35: 2065–9
- Hanninen M L, Pajarre S, Klossner M L, Rautelin H. Typing of human Campylobacter jejuni isolates in Finland by pulsed-field gel electrophoresis. J Clin Microbiol 1998; 36: 1787–9
- Mattila L, Peltola H, Siitonen A, Kyronseppa H, Simula I, Kataja M. Short-term treatment of traveler's diarrhea with norfloxacin: a double-blind placebo-controlled study during two seasons. Clin Infect Dis 1993; 17: 779–82
- Kuschner R A, Trofa A F, Thomas R J, Hoge C W, Pitarangsi C, Amato S. Use of azithromycin for the treatment of campylobacter enteritis in travelers to Thailand, an area where ciprofloxacin resistance is prevalent. Clin Infect Dis 1995; 21: 536–41
- Jacobs-Reitsma W. Campylobacter in the food supply. Campylobacter, 2nd edn, I Nachamkin, MJ Blaser. American Society for Microbiology, Washington, DC 2000; 467–81
- Hanninen M-L, Perko-Makela P, Pitkala A, Rautelin H. A three-year study of Campylobacter jejuni genotypes in domestically acquired human infections and chicken meat samples from Helsinki area. J Clin Microbiol 2000; 38: 1998–2000
- Hanninen M.-L. Survival of Campylobacter jejuni/coli in ground refrigerated and in ground deep-frozen beef liver and in frozen broiler carcasses. Acta Vet Scand 1981; 22: 566–77
- Owen R J, Slater D, Telford D, Donovan T, Barnham M. Subtypes of Campylobacter jejuni from sporadic cases of diarrhoeal disease at different locations in England are highly diverse. Eur J Epidemiol 1997; 13: 837–40
- Newell D G, Frost J A, Duim B, Wagenaar J A, Madden R H, Van der Plas J. New developments in the subtyping of Campylobacter species. Campylobacter, 2nd edn, I Nachamkin, MJ Blaser. American Society for Microbiology, Washington, DC 2000; 2744